Hansoh Pharma Keeps Share Count Stable in March; Convertible Bonds Allow for Up to 81.55 Million New Shares

Bulletin Express04-02

Hansoh Pharmaceutical Group Company Limited reported no changes in either authorised or issued share capital for the month ended 31 March 2026. Authorised capital remained at 20.00 billion ordinary shares with a par value of HKD 0.00001, equivalent to HKD 0.20 million.

Issued share capital also held steady at 6.06 billion shares, and the company continued to hold no treasury shares. The board confirmed that public float requirements were satisfied, with at least 16.21 % of the share class in public hands.

Outstanding zero-coupon convertible bonds due 2033 totaled HKD 4.68 billion at month-end. If fully converted at the set price of HKD 57.39 per share, these bonds could generate up to 81.55 million new ordinary shares—representing roughly 1.35 % of the current issued share base.

No activity was recorded under share option schemes, warrants, other convertible instruments, or any additional equity agreements during the period. Ms. Zhong Shengli, Joint Company Secretary, submitted the monthly return on 2 April 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158463945?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-02 17:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158463945","market":"hk","top_or_hot":-1,"title":"Hansoh Pharma Keeps Share Count Stable in March; Convertible Bonds Allow for Up to 81.55 Million New Shares","media":"Bulletin Express","content":"<p>Hansoh Pharmaceutical Group Company Limited reported no changes in either authorised or issued share capital for the month ended 31 March 2026. Authorised capital remained at 20.00 billion ordinary shares with a par value of HKD 0.00001, equivalent to HKD 0.20 million.</p>\n<p>Issued share capital also held steady at 6.06 billion shares, and the company continued to hold no treasury shares. The board confirmed that public float requirements were satisfied, with at least 16.21 % of the share class in public hands.</p>\n<p>Outstanding zero-coupon convertible bonds due 2033 totaled HKD 4.68 billion at month-end. If fully converted at the set price of HKD 57.39 per share, these bonds could generate up to 81.55 million new ordinary shares—representing roughly 1.35 % of the current issued share base.</p>\n<p>No activity was recorded under share option schemes, warrants, other convertible instruments, or any additional equity agreements during the period. Ms. Zhong Shengli, Joint Company Secretary, submitted the monthly return on 2 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hansoh Pharma Keeps Share Count Stable in March; Convertible Bonds Allow for Up to 81.55 Million New Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHansoh Pharma Keeps Share Count Stable in March; Convertible Bonds Allow for Up to 81.55 Million New Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-04-02 17:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hansoh Pharmaceutical Group Company Limited reported no changes in either authorised or issued share capital for the month ended 31 March 2026. Authorised capital remained at 20.00 billion ordinary shares with a par value of HKD 0.00001, equivalent to HKD 0.20 million.</p>\n<p>Issued share capital also held steady at 6.06 billion shares, and the company continued to hold no treasury shares. The board confirmed that public float requirements were satisfied, with at least 16.21 % of the share class in public hands.</p>\n<p>Outstanding zero-coupon convertible bonds due 2033 totaled HKD 4.68 billion at month-end. If fully converted at the set price of HKD 57.39 per share, these bonds could generate up to 81.55 million new ordinary shares—representing roughly 1.35 % of the current issued share base.</p>\n<p>No activity was recorded under share option schemes, warrants, other convertible instruments, or any additional equity agreements during the period. Ms. Zhong Shengli, Joint Company Secretary, submitted the monthly return on 2 April 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03692","symbol_name":"翰森制药","start_time":0,"source_url":"","article_id":"1158463945","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158463945","pubTimestamp":1775120773,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hansoh Pharmaceutical Group Company Limited reported no changes in either authorised or issued share capital for the month ended 31 March 2026. Authorised capital remained at 20.00 billion ordinary...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03692":"翰森制药"},"translate_title":"豪森药业3月份股数保持稳定；可转换债券最多允许8155万股新股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03692":1},"content_text":"Hansoh Pharmaceutical Group Company Limited reported no changes in either authorised or issued share capital for the month ended 31 March 2026. Authorised capital remained at 20.00 billion ordinary shares with a par value of HKD 0.00001, equivalent to HKD 0.20 million.\nIssued share capital also held steady at 6.06 billion shares, and the company continued to hold no treasury shares. The board confirmed that public float requirements were satisfied, with at least 16.21 % of the share class in public hands.\nOutstanding zero-coupon convertible bonds due 2033 totaled HKD 4.68 billion at month-end. If fully converted at the set price of HKD 57.39 per share, these bonds could generate up to 81.55 million new ordinary shares—representing roughly 1.35 % of the current issued share base.\nNo activity was recorded under share option schemes, warrants, other convertible instruments, or any additional equity agreements during the period. Ms. Zhong Shengli, Joint Company Secretary, submitted the monthly return on 2 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX,express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158463945","isCrawlerRequest":true}